Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001594062-17-000118
Filing Date
2017-05-15
Accepted
2017-05-15 16:27:22
Documents
42
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 324007
2 CERTIFICATION ex311.htm EX-31.1 19149
3 CERTIFICATION ex321.htm EX-32.1 8444
  Complete submission text file 0001594062-17-000118.txt   1789120

Data Files

Seq Description Document Type Size
4 XBRL CALCULATION LINKBASE cik0001689084-20170331_cal.xml EX-101.CAL 19655
5 XBRL DEFINITIONS LINKBASE cik0001689084-20170331_def.xml EX-101.DEF 53335
6 XBRL INSTANCE LINKBASE cik0001689084-20170331.xml EX-101.INS 253864
7 XBRL LABELS LINKBASE cik0001689084-20170331_lab.xml EX-101.LAB 192093
8 XBRL PRESENTATION LINKBASE cik0001689084-20170331_pre.xml EX-101.PRE 128803
9 XBRL SCHEMA LINKBASE cik0001689084-20170331.xsd EX-101.SCH 22869
Mailing Address 1900 PURDY AVENUE #1907 MIAMI BEACH FL 33139
Business Address 777 BRICKELL AVENUE SUITE 500 MIAMI FL 33131 7866202140
BIOLABMART INC. (Filer) CIK: 0001689084 (see all company filings)

EIN.: 813623646 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-216650 | Film No.: 17844680
SIC: 2836 Biological Products, (No Diagnostic Substances)